PTPN2 and adoptive T cell immunotherapy

Lead researcher

Dr Florian Wiede

Institution

Monash University, Department of Biochemistry and Molecular Biology

Years funded

2016-2018

This project will determine whether the immune response to tumours can be enhanced by targeting an inhibitory molecule known as PTPN2. The results will lead to a new and more effective approach for cancer treatment.

Funding Body

Cancer Council Research Grant

Funding

$100,000 pa for three years

Updated: